Composition

Each 1 ml contains:
Betaxolol hydrochloride ................................ 5.6 mg
Equivalent to Betaxolol .................................. 5 mg
Inactive ingredients: Benzalkonium chloride, disodium edetate, sodium chloride, sodium hydroxide, water of injection.

Therapeutic Indications

EPITAXOL is indicated for the reduction of elevated intraocular pressure in patients with ocular hypertension and chronic open angle glaucoma.

Dosage and Administration

Adults (including the Elderly):
The usual dose is one drop to be instilled into the affected eye(s) twice daily.
Children:
EPITAXOL is not recommended for use in children.
When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced.
This may result in a decrease in systemic side effects and an increase in local activity.

Contraindications

Hypersensitivity to the active substance or to any of the excipients.
Reactive airway disease including severe bronchial asthma or a history of severe bronchial asthma, severe chronic obstructive pulmonary disease.
Sinus bradycardia, sick sinus syndrome, sino-atrial block, second or third degree atrioventricular block not controlled with pace-maker.
Overt cardiac failure, cardiogenic shock.